Author

Andrew David Brim

Mayo ClinicORCID 0009-0000-1177-5272Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Aleeshba N. BasiliD· 1 shared Alfredo Quiñones‐HinojosaiD· 1 shared Cristina Gomez-PalmeroiD· 1 shared Frederick Q Tutor‐New· 1 shared Haidong DongiD· 1 shared Hong QiniD· 1 shared Jacob B. HirdleriD· 1 shared Jesus Emiliano Sanchez-GaravitoiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aleeshba N. BasilORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintNov 22, 2024

Single CAR-Dual target: Intracranial Delivery of Anti-PD-L1 CAR T Cells Effectively Eradicates Glioma and Immunosuppressive Cells in the Tumor Microenvironment.

María José Ulloa-Navas, Yan Luo, Jesus Emiliano Sanchez-Garavito…·Alfredo Quiñones‐Hinojosa

This study develops a PD-L1-targeting CAR T cell therapy, MC9999, which effectively eradicates glioblastoma and immunosuppressive cells in the tumor microenvironment through intracranial delivery.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky